Role of associated gamma-chain in tyrosine kinase activation via murine Fc gamma RIII.

PubWeight™: 1.20‹?› | Rank: Top 10%

🔗 View Article (PMC 556750)

Published in EMBO J on July 01, 1992

Authors

C Bonnerot1, S Amigorena, D Choquet, R Pavlovich, V Choukroun, W H Fridman

Author Affiliations

1: Laboratoire d'Immunologie Cellulaire et Clinique, INSERM U.255, Institut Curie, Paris, France.

Articles citing this

Fcgamma receptor-mediated induction of dendritic cell maturation and major histocompatibility complex class I-restricted antigen presentation after immune complex internalization. J Exp Med (1999) 5.55

The dendritic cell receptor for endocytosis, DEC-205, can recycle and enhance antigen presentation via major histocompatibility complex class II-positive lysosomal compartments. J Cell Biol (2000) 2.90

A novel inhibitory receptor (ILT3) expressed on monocytes, macrophages, and dendritic cells involved in antigen processing. J Exp Med (1997) 2.05

Cell surface control of the multiubiquitination and deubiquitination of high-affinity immunoglobulin E receptors. EMBO J (1993) 1.53

The (YXXL/I)2 signalling motif found in the cytoplasmic segments of the bovine leukaemia virus envelope protein and Epstein-Barr virus latent membrane protein 2A can elicit early and late lymphocyte activation events. EMBO J (1993) 1.49

CD3+CD16+NK1.1+B220+ large granular lymphocytes arise from both alpha-beta TCR+CD4-CD8- and gamma-delta TCR+CD4-CD8- cells. J Exp Med (1994) 1.19

syk protein tyrosine kinase regulates Fc receptor gamma-chain-mediated transport to lysosomes. EMBO J (1998) 1.19

Type II and III receptors for immunoglobulin G (IgG) control the presentation of different T cell epitopes from single IgG-complexed antigens. J Exp Med (1998) 1.11

Delineation of a T-cell activation motif required for binding of protein tyrosine kinases containing tandem SH2 domains. Proc Natl Acad Sci U S A (1994) 1.07

Syk-dependent actin dynamics regulate endocytic trafficking and processing of antigens internalized through the B-cell receptor. Mol Biol Cell (2007) 1.02

Role of Fc gamma receptors in triggering host cell activation and cytokine release by Borrelia burgdorferi. Infect Immun (2001) 1.00

Syk tyrosine kinase and B cell antigen receptor (BCR) immunoglobulin-alpha subunit determine BCR-mediated major histocompatibility complex class II-restricted antigen presentation. J Exp Med (1998) 0.99

Cross-linking of IgG receptors inhibits membrane immunoglobulin-stimulated calcium influx in B lymphocytes. J Cell Biol (1993) 0.98

Autonomous phagosomal degradation and antigen presentation in dendritic cells. Proc Natl Acad Sci U S A (2012) 0.98

Lineage-independent activation of immune system effector function by myeloid Fc receptors. EMBO J (1992) 0.88

Different roles for the Fc epsilon RI gamma chain as a function of the receptor context. J Exp Med (1995) 0.85

Articles cited by this

Electroporation for the efficient transfection of mammalian cells with DNA. Nucleic Acids Res (1987) 12.80

Characterization of a monoclonal antibody directed against mouse macrophage and lymphocyte Fc receptors. J Exp Med (1979) 12.22

The cytoplasmic domain of the T cell receptor zeta chain is sufficient to couple to receptor-associated signal transduction pathways. Cell (1991) 6.13

T cell antigen receptor activation pathways: the tyrosine kinase connection. Cell (1991) 3.95

Association of B cell antigen receptor with protein tyrosine kinase Lyn. Science (1991) 3.86

Anti-immunoglobulin stimulation of B lymphocytes activates src-related protein-tyrosine kinases. Proc Natl Acad Sci U S A (1991) 3.57

Alternative membrane forms of Fc gamma RIII(CD16) on human natural killer cells and neutrophils. Cell type-specific expression of two genes that differ in single nucleotide substitutions. J Exp Med (1989) 3.36

Membrane protein association by potential intramembrane charge pairs. Nature (1991) 3.27

T cell antigen receptor-mediated activation of phospholipase C requires tyrosine phosphorylation. Science (1990) 3.23

The T cell receptor/CD3 complex is composed of at least two autonomous transduction modules. Cell (1992) 3.11

Molecular components of the B-cell antigen receptor complex of the IgM class. Nature (1990) 3.06

Complete structure and expression in transfected cells of high affinity IgE receptor. Nature (1989) 2.97

Engagement of the high-affinity IgE receptor activates src protein-related tyrosine kinases. Nature (1992) 2.95

Co-association of CD3 zeta with a receptor (CD16) for IgG Fc on human natural killer cells. Nature (1989) 2.91

Structural heterogeneity and functional domains of murine immunoglobulin G Fc receptors. Science (1986) 2.89

Interaction of Fc receptor (CD16) ligands induces transcription of interleukin 2 receptor (CD25) and lymphokine genes and expression of their products in human natural killer cells. J Exp Med (1988) 2.79

The zeta chain is associated with a tyrosine kinase and upon T-cell antigen receptor stimulation associates with ZAP-70, a 70-kDa tyrosine phosphoprotein. Proc Natl Acad Sci U S A (1991) 2.74

Activation of T cells by a tyrosine kinase activation domain in the cytoplasmic tail of CD3 epsilon. Science (1992) 2.67

Fc receptor isoforms exhibit distinct abilities for coated pit localization as a result of cytoplasmic domain heterogeneity. Cell (1989) 2.58

Molecular cloning of the zeta chain of the T cell antigen receptor. Science (1988) 2.58

A macrophage Fc gamma receptor and the mast cell receptor for IgE share an identical subunit. Nature (1989) 2.55

Cellular immunity to HIV activated by CD4 fused to T cell or Fc receptor polypeptides. Cell (1991) 2.45

CD3 stimulation causes phosphorylation of phospholipase C-gamma 1 on serine and tyrosine residues in a human T-cell line. Proc Natl Acad Sci U S A (1991) 2.37

T-cell and basophil activation through the cytoplasmic tail of T-cell-receptor zeta family proteins. Proc Natl Acad Sci U S A (1991) 2.32

A peptide sequence confers retention and rapid degradation in the endoplasmic reticulum. Science (1990) 2.17

Fc gamma R(CD16) interaction with ligand induces Ca2+ mobilization and phosphoinositide turnover in human natural killer cells. Role of Ca2+ in Fc gamma R(CD16)-induced transcription and expression of lymphokine genes. J Exp Med (1989) 2.16

Cross-linking of B lymphocyte Fc gamma receptors and membrane immunoglobulin inhibits anti-immunoglobulin-induced blastogenesis. J Immunol (1984) 2.15

Family of disulphide-linked dimers containing the zeta and eta chains of the T-cell receptor and the gamma chain of Fc receptors. Nature (1990) 2.14

The T cell antigen receptor zeta chain is tyrosine phosphorylated upon activation. J Biol Chem (1988) 2.04

Tyrosine phosphorylation coupled to IgE receptor-mediated signal transduction and histamine release. Proc Natl Acad Sci U S A (1990) 1.98

Phosphorylation and dephosphorylation of the high-affinity receptor for immunoglobulin E immediately after receptor engagement and disengagement. Nature (1991) 1.96

A single amino acid in the glycosyl phosphatidylinositol attachment domain determines the membrane topology of Fc gamma RIII. Nature (1989) 1.91

A complementary DNA clone for a macrophage-lymphocyte Fc receptor. Nature (1987) 1.76

Regulation of B cell antigen receptor signal transduction and phosphorylation by CD45. Science (1991) 1.66

Isolation of a cDNA copy of an RNA species expressed in murine pre-B cells. EMBO J (1986) 1.63

Crosslinking by ligands to surface immunoglobulin triggers mobilization of intracellular 45Ca2+ in B lymphocytes. J Cell Biol (1979) 1.49

Structural mutations of the T cell receptor zeta chain and its role in T cell activation. Science (1990) 1.44

Anti-Ig induces release of inositol 1,4,5-trisphosphate, which mediates mobilization of intracellular Ca++ stores in B lymphocytes. J Immunol (1986) 1.43

Tyrosine phosphorylation of the Fc gamma RIII(CD16): zeta complex in human natural killer cells. Induction by antibody-dependent cytotoxicity but not by natural killing. J Immunol (1991) 1.43

Antibody-cell interactions: Fc receptors. Cell (1989) 1.41

The role of tyrosine phosphorylation in signal transduction through surface Ig in human B cells. Inhibition of tyrosine phosphorylation prevents intracellular calcium release. J Immunol (1991) 1.36

T cell receptor complexes containing Fc epsilon RI gamma homodimers in lieu of CD3 zeta and CD3 eta components: a novel isoform expressed on large granular lymphocytes. J Exp Med (1992) 1.25

Structural bases of Fc gamma receptor functions. Immunol Rev (1992) 1.23

Murine natural killer cells express functional Fc gamma receptor II encoded by the Fc gamma R alpha gene. J Exp Med (1989) 1.20

The mouse Fc receptor for IgG (Ly-17): molecular cloning and specificity. Immunogenetics (1987) 1.13

Different phenotypic variants of the mouse B cell tumor A20/2J are selected by antigen- and mitogen-triggered cytotoxicity of L3T4-positive, I-A-restricted T cell clones. J Immunol (1986) 1.13

Subunit interactions within the T-cell antigen receptor: clues from the study of partial complexes. Proc Natl Acad Sci U S A (1988) 1.08

Production of multiple lymphokines by the A20.1 B cell lymphoma after cross-linking of membrane Ig by immobilized anti-Ig. J Immunol (1989) 0.95

Signal transmission through the B cell-specific MB-1 molecule at the pre-B cell stage. Int Immunol (1991) 0.94

Fc gamma RII expression in resting and activated B lymphocytes. Eur J Immunol (1989) 0.86

Unmethylation of specific sites in the 5' region is critical for the expression of murine alpha Fc gamma R gene. J Immunol (1990) 0.79

Articles by these authors

Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes. Nat Med (1998) 6.36

Proteomic analysis of dendritic cell-derived exosomes: a secreted subcellular compartment distinct from apoptotic vesicles. J Immunol (2001) 6.32

Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming. Nat Med (2001) 5.71

Fcgamma receptor-mediated induction of dendritic cell maturation and major histocompatibility complex class I-restricted antigen presentation after immune complex internalization. J Exp Med (1999) 5.55

Molecular characterization of dendritic cell-derived exosomes. Selective accumulation of the heat shock protein hsc73. J Cell Biol (1999) 4.87

Selective transport of internalized antigens to the cytosol for MHC class I presentation in dendritic cells. Nat Cell Biol (1999) 4.53

The calcium current activated by T cell receptor and store depletion in human lymphocytes is absent in a primary immunodeficiency. J Biol Chem (1994) 2.92

Stimulation of lymphocytes by autologous leukaemic cells in acute leukaemia. Nature (1969) 2.75

Complement factor I: a susceptibility gene for atypical haemolytic uraemic syndrome. J Med Genet (2004) 2.55

Cytoplasmic domain heterogeneity and functions of IgG Fc receptors in B lymphocytes. Science (1992) 2.41

Ligand binding regulates the directed movement of beta1 integrins on fibroblasts. Nature (1996) 2.40

Fast and reversible trapping of surface glycine receptors by gephyrin. Nat Neurosci (2001) 2.37

The structure of a human type III Fcgamma receptor in complex with Fc. J Biol Chem (2001) 2.33

FcgammaRI (CD64) contributes substantially to severity of arthritis, hypersensitivity responses, and protection from bacterial infection. Immunity (2002) 2.31

Interleukin 17, a T-cell-derived cytokine, promotes tumorigenicity of human cervical tumors in nude mice. Cancer Res (1999) 2.23

The same tyrosine-based inhibition motif, in the intracytoplasmic domain of Fc gamma RIIB, regulates negatively BCR-, TCR-, and FcR-dependent cell activation. Immunity (1995) 2.12

Single metallic nanoparticle imaging for protein detection in cells. Proc Natl Acad Sci U S A (2003) 2.10

TGF-beta 1 prevents the noncognate maturation of human dendritic Langerhans cells. J Immunol (1999) 2.05

Cell migration as a five-step cycle. Biochem Soc Symp (1999) 1.88

Cell-mediate cytotoxicity in vitro of human lymphocytes against a tissue culture melanoma cell line (igr3). J Immunol (1975) 1.82

Bacteria-induced neo-biosynthesis, stabilization, and surface expression of functional class I molecules in mouse dendritic cells. Proc Natl Acad Sci U S A (1998) 1.74

Infusion of Fc gamma fragments for treatment of children with acute immune thrombocytopenic purpura. Lancet (1993) 1.72

Prognostic value of intratumoral interferon gamma messenger RNA expression in invasive cervical carcinomas. J Natl Cancer Inst (1998) 1.71

Regulation of high-affinity IgE receptor-mediated mast cell activation by murine low-affinity IgG receptors. J Clin Invest (1995) 1.70

Calcium influx through nicotinic receptor in rat central neurons: its relevance to cellular regulation. Neuron (1992) 1.68

The cell biology of antigen presentation in dendritic cells. Curr Opin Immunol (2001) 1.63

Deficient peptide loading and MHC class II endosomal sorting in a human genetic immunodeficiency disease: the Chediak-Higashi syndrome. J Cell Biol (1998) 1.60

Tyrosine-containing motif that transduces cell activation signals also determines internalization and antigen presentation via type III receptors for IgG. Nature (1992) 1.60

The high frequency of complement factor H related CFHR1 gene deletion is restricted to specific subgroups of patients with atypical haemolytic uraemic syndrome. J Med Genet (2009) 1.59

The invariant chain is required for intracellular transport and function of major histocompatibility complex class II molecules. J Exp Med (1994) 1.59

Serum soluble interleukin-2 receptor concentrations as an independent prognostic marker in head and neck cancer. Lancet (2001) 1.58

Angiogenesis and immunity: a bidirectional link potentially relevant for the monitoring of antiangiogenic therapy and the development of novel therapeutic combination with immunotherapy. Cancer Metastasis Rev (2011) 1.55

Characterization and function of T cell Fc gamma receptor. Immunol Rev (1981) 1.50

The (YXXL/I)2 signalling motif found in the cytoplasmic segments of the bovine leukaemia virus envelope protein and Epstein-Barr virus latent membrane protein 2A can elicit early and late lymphocyte activation events. EMBO J (1993) 1.49

A primary T-cell immunodeficiency associated with defective transmembrane calcium influx. Blood (1995) 1.48

Differential modulation of stimulatory and inhibitory Fc gamma receptors on human monocytes by Th1 and Th2 cytokines. J Immunol (2001) 1.48

T-cell hybrids bear Fcgamma receptors and secrete suppressor immunoglobulin binding factor. Nature (1979) 1.47

Suppression of in vitro antibody synthesis by immunoglobulin-binding factor. J Exp Med (1975) 1.37

Highly resolved chemical imaging of living cells by using synchrotron infrared microspectrometry. Proc Natl Acad Sci U S A (1998) 1.36

Wavelet analysis for single molecule localization microscopy. Opt Express (2012) 1.36

Cyclic AMP-modulated potassium channels in murine B cells and their precursors. Science (1987) 1.35

Tumor-derived exosomes: a new source of tumor rejection antigens. Vaccine (2002) 1.33

Ii chain controls the transport of major histocompatibility complex class II molecules to and from lysosomes. J Cell Biol (1997) 1.30

Fc epsilon receptor I-associated lyn-dependent phosphorylation of Fc gamma receptor IIB during negative regulation of mast cell activation. J Immunol (1998) 1.28

Absence of allogeneic restriction in human T-cell-mediated cytotoxicity to Epstein-Barr virus-infected target cells. Demonstration of an HLA-linked control at the effector level. J Exp Med (1979) 1.27

Significance of highly positive c22-3 "indeterminate" second-generation hepatitis C virus (HCV) recombinant immunoblot assay (RIBA) and resolution by third-generation HCV RIBA. J Clin Microbiol (1994) 1.26

Variable expression of CD3-zeta chain in tumor-infiltrating lymphocytes (TIL) derived from renal-cell carcinoma: relationship with TIL phenotype and function. Int J Cancer (1995) 1.25

Role of B cell receptor Ig alpha and Ig beta subunits in MHC class II-restricted antigen presentation. Immunity (1995) 1.25

Surface trafficking of N-methyl-D-aspartate receptors: physiological and pathological perspectives. Neuroscience (2008) 1.25

Structural bases of Fc gamma receptor functions. Immunol Rev (1992) 1.23

Isotype regulation of antibody production: T-cell hybrids can be selectively induced to produce IgG1 and IgG2 subclass-specific suppressive immunoglobulin-binding factors. Proc Natl Acad Sci U S A (1983) 1.19

syk protein tyrosine kinase regulates Fc receptor gamma-chain-mediated transport to lysosomes. EMBO J (1998) 1.19

Complement mutation-associated de novo thrombotic microangiopathy following kidney transplantation. Am J Transplant (2008) 1.17

Vimentin filaments in fibroblasts are a reservoir for SNAP23, a component of the membrane fusion machinery. Mol Biol Cell (2000) 1.15

Suppression of mitogen-induced peripheral B cell differentiation by soluble Fc gamma receptors released from lymphocytes. Eur J Immunol (1980) 1.14

Chemical imaging of nucleic acids, proteins and lipids of a single living cell. Application of synchrotron infrared microspectrometry in cell biology. Cell Mol Biol (Noisy-le-grand) (1998) 1.13

A role for HLA-DO as a co-chaperone of HLA-DM in peptide loading of MHC class II molecules. EMBO J (1998) 1.13

Serum interleukin 6 and C-reactive protein levels correlate with resistance to IL-2 therapy and poor survival in melanoma patients. Br J Cancer (1994) 1.12

Modulation of interleukin-18 expression in human colon carcinoma: consequences for tumor immune surveillance. Int J Cancer (1999) 1.11

Macrophage inflammatory protein-1alpha is induced by human immunodeficiency virus infection of monocyte-derived macrophages. Blood (1996) 1.11

T cell hybridomas coexpressing Fc receptors (FcR) for different isotypes. II. IgA-induced formation of suppressive IgA binding factor(s) by a murine T hybridoma bearing Fc gamma R and Fc alpha R. J Immunol (1983) 1.10

Immunoglobulin-binding factor present on and produced by thymus-processed lymphocytes (T cells). Cell Immunol (1974) 1.10

HLA-DM is localized to conventional and unconventional MHC class II-containing endocytic compartments. Immunity (1996) 1.09

The role of the Fc receptor (FcR) of thymus-derived lymphocytes. II. Presence of FcR on suppressor cells and direct involvement in suppression. Eur J Immunol (1977) 1.09

A phase II study of the cancer vaccine TG4010 alone and in combination with cytokines in patients with metastatic renal clear-cell carcinoma: clinical and immunological findings. Cancer Immunol Immunother (2010) 1.08

Interferon enhances the expression of Fc gamma receptors. J Immunol (1980) 1.08

The B subunit of Shiga toxin fused to a tumor antigen elicits CTL and targets dendritic cells to allow MHC class I-restricted presentation of peptides derived from exogenous antigens. J Immunol (2000) 1.07

Induction of tolerance by exosomes and short-term immunosuppression in a fully MHC-mismatched rat cardiac allograft model. Am J Transplant (2006) 1.07

Interleukin-18: biological properties and clinical implications. Eur Cytokine Netw (2000) 1.06

Soluble Fcgamma receptor type III (FcgammaRIII, CD16) triggers cell activation through interaction with complement receptors. J Immunol (1996) 1.05

Differential roles of N- and C-terminal immunoreceptor tyrosine-based inhibition motifs during inhibition of cell activation by killer cell inhibitory receptors. J Immunol (1999) 1.05

Ion channel blockers inhibit B cell activation at a precise stage of the G1 phase of the cell cycle. Possible involvement of K+ channels. J Immunol (1990) 1.05

Signal regulatory proteins negatively regulate immunoreceptor-dependent cell activation. J Biol Chem (1999) 1.00

Paucity of functional T-cell memory to melanoma antigens in healthy donors and melanoma patients. Clin Cancer Res (2000) 1.00

Doppler echocardiographic evaluation of valve regurgitation in healthy volunteers. Br Heart J (1993) 0.99

Cross-linking of IgG receptors inhibits membrane immunoglobulin-stimulated calcium influx in B lymphocytes. J Cell Biol (1993) 0.98

Regulation of ITAM signaling by specific sequences in Ig-beta B cell antigen receptor subunit. J Biol Chem (1996) 0.98

Induction of tumor necrosis factor-alpha production by mast cells via Fc gamma R. Role of the Fc gamma RIII gamma subunit. J Immunol (1992) 0.98

Recombinant interleukin 2-activated natural killer cells regulate IgG2a production. Eur J Immunol (1990) 0.98

Predictors of clinical response to interleukin-2--based immunotherapy in melanoma patients: a French multiinstitutional study. J Clin Oncol (1996) 0.97

Selective in vivo recruitment of the phosphatidylinositol phosphatase SHIP by phosphorylated Fc gammaRIIB during negative regulation of IgE-dependent mouse mast cell activation. Immunol Lett (1996) 0.97

Murine recombinant Fc gamma RIII, but not Fc gamma RII, trigger serotonin release in rat basophilic leukemia cells. J Immunol (1992) 0.97

Different patterns of calcium signaling triggered through two components of the B lymphocyte antigen receptor. J Biol Chem (1994) 0.97

Cytokines and soluble cytokine receptor induction after IL-12 administration in cancer patients. Clin Exp Immunol (2000) 0.97

Production of an immunoglobulin-binding factor (IBF) by antigen-stimulated lymph node lymphocytes. J Immunol (1974) 0.97

Intracellular expression of an antibody fragment-neutralizing p21 ras promotes tumor regression. Cancer Res (1998) 0.96

Differential regulation of voltage- and calcium-activated potassium channels in human B lymphocytes. J Immunol (1992) 0.96

A tyrosine-based signal present in Ig alpha mediates B cell receptor constitutive internalization. J Immunol (1998) 0.96

Molecular heterogeneity of murine mast cell Fc gamma receptors. J Immunol (1990) 0.96

Antigen traffic pathways in dendritic cells. Traffic (2000) 0.96

A new set of monoclonal antibodies against human Fc gamma RII (CD32) and Fc gamma RIII (CD16): characterization and use in various assays. Hybridoma (1997) 0.95

Recombinant soluble receptors for the Fc gamma portion inhibit antibody production in vitro. Eur J Immunol (1989) 0.95

Human virus-infected target cells lacking HLA antigens resist specific T-lymphocyte cytolysis. Nature (1977) 0.95

Development of a direct in situ RT-PCR method using labeled primers to detect cytokine mRNA inside cells. J Immunol Methods (1999) 0.94

Dendritic cells or their exosomes are effective biotherapies of cancer. Eur J Cancer (1999) 0.94